36 / 48
78
VOLUME 12 NUMBER 2 • NOVEMBER 2015
RESEARCH ARTICLE
SA JOURNAL OF DIABETES & VASCULAR DISEASE
10. Wachtell K, Olsen MH, Dahlof B,
et al
. Microalbuminuria in hypertensive patients
with electrocardiographic left ventricular hypertrophy: the LIFE study.
J Hypertens
2002;
20
: 405−412.
11. Huston SL, Bunker CH, Ukoli FA,
et al
. Electrocardiographic left ventricular
hypertrophy by five criteria among civil servants in Benin City, Nigeria: prevalence
and correlates. Int J Cardiol 1999; 70: 1−14.
12. Dada A, Adebiyi AA, Aje A,
et al
. Standard electrocardiographic criteria for left
ventricular hypertrophy in Nigerian hypertensives.
Ethn Dis
2005;
15
: 578−584.
13. Lepira FB, Kayembe PK, M'Buyamba-Kabangu JR,
et al
. Clinical correlates of left
ventricular hypertrophy in black patients with arterial hypertension.
Cardiovasc J
South Afr
2006;
17
: 7−11.
14. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus
and its complications. Part 1: diagnosis and classification of diabetes mellitus
provisional report of a WHO consultation.
Diabet Med
1998;
15
: 539−553.
15. Physical status: the use and interpretation of anthropometry. Report of a WHO
Expert Committee.
Wld Hlth Organ Tech Rep Ser
1995;
854
: 1−452.
16. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight
and Obesity in Adults − The Evidence Report. National Institutes of Health.
Obes
Res
1998;
6
(Suppl 2): 51S−209S.
17. Sokolow M, Freidlander RD. The normal unipolar precordial and limb lead
electrocardiogram.
Am Heart J
1949;
38
: 665−687.
18. Norman JE (jun), Levy D, Campbell G,
et al
. Improved detection of
echocardiographic left ventricular hypertrophy using a new electrocardiographic
algorithm.
J Am Coll Cardiol
1993;
21
: 1680−1686.
19. Molloy TJ, Okin PM, Devereux RB,
et al
. Electrocardiographic detection of left
ventricular hypertrophy by the simple QRS voltage-duration product.
J Am Coll
Cardiol
1992;
20
: 1180−1186.
20. Okin PM, Roman MJ, Devereux RB,
et al
. Gender differences and the electro-
cardiogram in left ventricular hypertrophy.
Hypertension
1995;
25
: 242−249.
21. Okin PM, Roman MJ, Devereux RB,
et al
. Electrocardiographic identification of
increased left ventricular mass by simple voltage-duration products.
J Am Coll
Cardiol
1995;
25
: 417−423.
22. Prineas RJ CR, Blackburn H. The Minnesota Code Manual of Electrocardiographic
Findings: Standards and Procedures for Measurement and Classification. London:
John Wright, 1982.
23. The Diabetes Research in Children Network (DirectNet) Study Group. Comparison
of fingerstick hemoglobin A
1c
levels assayed by DCA2000 with the DCCT/EDIC
central laboratory assay: results of a Diabetes Research in Children Network
(DirectNet) Study.
Pediat Diabetes
2005;
6
: 13−16.
24. 1999 World Health Organization-International Society of Hypertension Guidelines
for the Management of Hypertension. Guidelines Subcommittee.
J Hypertens
1999;
17
: 151−183.
25. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index
explains obesity-related health risk.
Am J Clin Nutr
2004;
79
: 379−384.
26. 2003 European Society of Hypertension−European Society of Cardiology
guidelines for the management of arterial hypertension.
J Hypertens
2003;
21
:
1011−1053.
27. Yonga GO, Ogola EN, Juma FD. Cardiovascular risk factor profiles in mild to
moderate hypertensives seen at Kenyatta National Hospital.
East Afr Med J
1993;
70
: 693−695.
28. Chapman JN, Mayet J, Chang CL,
et al
. Ethnic differences in the identification of
left ventricular hypertrophy in the hypertensive patient.
Am J Hypertens
1999;
12
: 437−442.
29. Giunti S, Bruno G, Veglio M,
et al
. Electrocardiographic left ventricular
hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease
and cardiovascular risk factors: the Eurodiab IDDM Complications Study.
Diabetes
Care
2005;
28
: 2255−2257.
30. Jaggy C, Perret F, Bovet P,
et al
. Performance of classic electrocardiographic
criteria for left ventricular hypertrophy in an African population.
Hypertension
2000;
36
: 54−61.
31. Summerson JH, Bell RA, Konen JC,
et al
. Differential impact of cardiovascular
disease (CVD) risk factor clustering on CVD and renal disease among African-
American and white patients with type 2 diabetes mellitus.
Ethn Dis
2002;
12
:
530−534.
32. Kaukua J, Turpeinen A, Uusitupa M,
et al
. Clustering of cardiovascular risk factors
in type 2 diabetes mellitus: prognostic significance and tracking.
Diabetes Obes
Metab
2001;
3
: 17−23.
33. Okin PM, Devereux RB, Jern S,
et al.
Baseline characteristics in relation to
electrocardiographic left ventricular hypertrophy in hypertensive patients: the
Losartan intervention for endpoint reduction (LIFE) in hypertension study. The
Life Study Investigators.
Hypertension
2000;
36
: 766−773.
34. Bruno G, Giunti S, Bargero G,
et al
. Sex-differences in prevalence of
electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale
Monferrato Study.
Diabet Med
2004;
21
: 823−828.
35. Rutter MK, McComb JM, Forster J,
et al
. Increased left ventricular mass index and
nocturnal systolic blood pressure in patients with Type 2 diabetes mellitus and
microalbuminuria.
Diabet Med
2000;
17
: 321−325.
36. Mbanya JC, Sobngwi E, Mbanya DS,
et al
. Left ventricular mass and systolic
function in African diabetic patients: association with microalbuminuria.
Diabetes
Metab
2001;
27
: 378−382.
37. Okin PM, Devereux RB, Nieminen MS,
et al
. Relationship of the electrocardiographic
strain pattern to left ventricular structure and function in hypertensive patients:
the LIFE study. Losartan Intervention For End point.
J Am Coll Cardiol
2001;
38
:
514−520.
38. Levy D, Labib SB, Anderson KM,
et al
. Determinants of sensitivity and specificity
of electrocardiographic criteria for left ventricular hypertrophy.
Circulation
1990;
81
: 815−820.